Quality of life with functional pharyngeal preservation in advanced carcinomas of the base tongue complex using an integrated trimodality approach

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 6, 2001, Pages 623-627

  Albuquerque, K ^a   Cirrone, J ^a   Aziz, H ^a,b   Har El, G ^a   Sundaram, K ^a   Dipillo, F ^a   Fulton, L ^a   Aral, I ^a   Schulsinger, A ^a   Rotman, M ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Base of tongue; Concomitant chemoradiation; Organ preservation

Indexed keywords

CISPLATIN; FLUOROURACIL; RADIOPROTECTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ORGAN PRESERVATION; PHARYNX; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; SURVIVAL RATE; TONGUE CARCINOMA; TOXICITY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DEGLUTITION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PHARYNX; QUALITY OF LIFE; REMISSION INDUCTION; SPEECH; TONGUE NEOPLASMS;

EID: 0035205907     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200112000-00020     Document Type: Article

References (19)

1. Organ/function preservation treatment in cancer of the oropharynx
2. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group
3. Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue
4. A Performance Status Scale for head and neck cancer patients
5. NCCN practice guidelines for head and neck cancer
6. Head and neck cancer
7. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003
8. Hyperfractionated radiotherapy of human tumors: Overview of the Randomized Clinical Trials
9. Concurrent chemoradiation in the treatment of head and neck cancer
10. Radiation therapy versus concomitant chemoradiotherapy for stages III/IV oropharynx cancer. A GORTEC randomized trial
11. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
12. Concurrent radiotherapy and chemotherapy with cis-platinum in inoperable squamous cell carcinoma of the head and neck. An RTOG study
13. Combined submultaneous cis-platinum fluorouracil chemotherapy and radiation and head and neck cancer
14. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer
15. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?
16. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
17. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: Overview of randomized trials
18. An overview of randomized controlled trial of adjuvant chemotherapy in head and neck cancer